TARA
Price
$5.03
Change
-$0.01 (-0.20%)
Updated
Jan 16, 11:53 AM (EDT)
Capitalization
270.08M
54 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$6.17
Change
-$0.02 (-0.32%)
Updated
Jan 16, 12:00 PM (EDT)
Capitalization
862.58M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TARA vs VIR

Header iconTARA vs VIR Comparison
Open Charts TARA vs VIRBanner chart's image
Protara Therapeutics
Price$5.03
Change-$0.01 (-0.20%)
Volume$1.1K
Capitalization270.08M
Vir Biotechnology
Price$6.17
Change-$0.02 (-0.32%)
Volume$700
Capitalization862.58M
TARA vs VIR Comparison Chart in %
View a ticker or compare two or three
VS
TARA vs. VIR commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TARA is a Hold and VIR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (TARA: $5.04 vs. VIR: $6.20)
Brand notoriety: TARA and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TARA: 103% vs. VIR: 114%
Market capitalization -- TARA: $270.08M vs. VIR: $862.58M
TARA [@Biotechnology] is valued at $270.08M. VIR’s [@Biotechnology] market capitalization is $862.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TARA’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 1 green FA rating(s).

  • TARA’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than TARA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TARA’s TA Score shows that 3 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • TARA’s TA Score: 3 bullish, 6 bearish.
  • VIR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VIR is a better buy in the short-term than TARA.

Price Growth

TARA (@Biotechnology) experienced а -10.16% price change this week, while VIR (@Biotechnology) price change was +4.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.20%. For the same industry, the average monthly price growth was +4.47%, and the average quarterly price growth was +43.25%.

Reported Earning Dates

TARA is expected to report earnings on Mar 11, 2026.

VIR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIR($863M) has a higher market cap than TARA($270M). VIR YTD gains are higher at: 2.819 vs. TARA (-5.441). TARA has higher annual earnings (EBITDA): -59.43M vs. VIR (-541.01M). VIR has more cash in the bank: 507M vs. TARA (133M). TARA has less debt than VIR: TARA (3.66M) vs VIR (100M). VIR has higher revenues than TARA: VIR (14M) vs TARA (0).
TARAVIRTARA / VIR
Capitalization270M863M31%
EBITDA-59.43M-541.01M11%
Gain YTD-5.4412.819-193%
P/E RatioN/AN/A-
Revenue014M-
Total Cash133M507M26%
Total Debt3.66M100M4%
FUNDAMENTALS RATINGS
TARA vs VIR: Fundamental Ratings
TARA
VIR
OUTLOOK RATING
1..100
257
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
5551
P/E GROWTH RATING
1..100
10029
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (20) in the null industry is in the same range as VIR (52). This means that TARA’s stock grew similarly to VIR’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as VIR (100). This means that TARA’s stock grew similarly to VIR’s over the last 12 months.

TARA's SMR Rating (97) in the null industry is in the same range as VIR (97). This means that TARA’s stock grew similarly to VIR’s over the last 12 months.

VIR's Price Growth Rating (51) in the null industry is in the same range as TARA (55). This means that VIR’s stock grew similarly to TARA’s over the last 12 months.

VIR's P/E Growth Rating (29) in the null industry is significantly better than the same rating for TARA (100). This means that VIR’s stock grew significantly faster than TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TARAVIR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
TARA
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GULTU0.050.01
+19.05%
Gulf Coast Ultra Deep Royalty Trust
FJTSF29.892.44
+8.89%
Fujitsu Ltd.
BYCRF42.33N/A
N/A
Baycurrent Consulting Inc.
VULNF3.21-0.12
-3.60%
Vulcan Energy Resources Ltd.
IQEPF0.13-0.01
-7.44%
IQE Plc

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with AMLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+2.02%
AMLX - TARA
41%
Loosely correlated
-3.91%
IMTX - TARA
39%
Loosely correlated
+0.92%
SYRE - TARA
39%
Loosely correlated
-0.21%
VIR - TARA
38%
Loosely correlated
-9.09%
RGNX - TARA
38%
Loosely correlated
-7.96%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-9.09%
BEAM - VIR
58%
Loosely correlated
-9.49%
IDYA - VIR
55%
Loosely correlated
-2.62%
XNCR - VIR
54%
Loosely correlated
-8.58%
XENE - VIR
52%
Loosely correlated
-2.02%
NUVL - VIR
52%
Loosely correlated
-1.56%
More